These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 30097823)

  • 1. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
    Chohan MO; Berger MS
    J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of 5-aminolevulinic acid on extent of resection in newly diagnosed high grade gliomas: a systematic review and single institutional experience.
    Haider SA; Lim S; Kalkanis SN; Lee IY
    J Neurooncol; 2019 Feb; 141(3):507-515. PubMed ID: 30506501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aminolevulinic acid for recurrent malignant gliomas: A systematic review.
    Broekx S; Weyns F; De Vleeschouwer S
    Clin Neurol Neurosurg; 2020 Aug; 195():105913. PubMed ID: 32447151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-ALA and FDA approval for glioma surgery.
    Hadjipanayis CG; Stummer W
    J Neurooncol; 2019 Feb; 141(3):479-486. PubMed ID: 30644008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative 5-ALA fluorescence-guided resection of high-grade glioma leads to greater extent of resection with better outcomes: a systematic review.
    Eatz TA; Eichberg DG; Lu VM; Di L; Komotar RJ; Ivan ME
    J Neurooncol; 2022 Jan; 156(2):233-256. PubMed ID: 34989964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
    Hickmann AK; Nadji-Ohl M; Hopf NJ
    J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence guided surgery by 5-ALA and intraoperative MRI in high grade glioma: a systematic review.
    Coburger J; Wirtz CR
    J Neurooncol; 2019 Feb; 141(3):533-546. PubMed ID: 30488293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence image-guided neurosurgery.
    Kaneko S; Eljamel MS
    Future Oncol; 2017 Nov; 13(26):2341-2348. PubMed ID: 29121788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
    Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
    World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aminolevulinic Acid-Shedding Light on Where to Focus.
    Dadario NB; Khatri D; Reichman N; Nwagwu CD; D'Amico RS
    World Neurosurg; 2021 Jun; 150():9-16. PubMed ID: 33684574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Established and emerging uses of 5-ALA in the brain: an overview.
    Díez Valle R; Hadjipanayis CG; Stummer W
    J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
    Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
    J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of high-grade glioma resection using 5-ALA fluorescence-guided surgery: A literature review and practical recommendations from the neuro-oncology club of the French society of neurosurgery.
    Picart T; Berhouma M; Dumot C; Pallud J; Metellus P; Armoiry X; Guyotat J
    Neurochirurgie; 2019 Aug; 65(4):164-177. PubMed ID: 31125558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature.
    Della Puppa A; De Pellegrin S; d'Avella E; Gioffrè G; Rossetto M; Gerardi A; Lombardi G; Manara R; Munari M; Saladini M; Scienza R
    Acta Neurochir (Wien); 2013 Jun; 155(6):965-72; discussion 972. PubMed ID: 23468036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
    Chan DTM; Yi-Pin Sonia H; Poon WS
    Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided surgery for high-grade gliomas.
    Lakomkin N; Hadjipanayis CG
    J Surg Oncol; 2018 Aug; 118(2):356-361. PubMed ID: 30125355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
    Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
    J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent high-grade glioma surgery: a multimodal intraoperative protocol to safely increase extent of tumor resection and analysis of its impact on patient outcome.
    Barbagallo GMV; Certo F; Di Gregorio S; Maione M; Garozzo M; Peschillo S; Altieri R
    Neurosurg Focus; 2021 Jan; 50(1):E20. PubMed ID: 33386001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.